Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

References for PMC Articles for PubMed (Select 20489057)

1.

A novel XIAP mutation in a Japanese boy with recurrent pancytopenia and splenomegaly.

Zhao M, Kanegane H, Ouchi K, Imamura T, Latour S, Miyawaki T.

Haematologica. 2010 Apr;95(4):688-9. doi: 10.3324/haematol.2009.018010. Epub 2009 Dec 16. No abstract available.

2.

Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency.

Snow AL, Marsh RA, Krummey SM, Roehrs P, Young LR, Zhang K, van Hoff J, Dhar D, Nichols KE, Filipovich AH, Su HC, Bleesing JJ, Lenardo MJ.

J Clin Invest. 2009 Oct;119(10):2976-89. doi: 10.1172/JCI39518. Epub 2009 Sep 14.

3.

Small molecule XIAP inhibitors sensitize childhood acute leukemia cells for CD95-induced apoptosis.

Loeder S, Drensek A, Jeremias I, Debatin KM, Fulda S.

Int J Cancer. 2010 May 1;126(9):2216-28. doi: 10.1002/ijc.24816.

PMID:
19676052
4.

XIAP mediates NOD signaling via interaction with RIP2.

Krieg A, Correa RG, Garrison JB, Le Negrate G, Welsh K, Huang Z, Knoefel WT, Reed JC.

Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14524-9. doi: 10.1073/pnas.0907131106. Epub 2009 Aug 10.

5.

Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations.

Marsh RA, Villanueva J, Kim MO, Zhang K, Marmer D, Risma KA, Jordan MB, Bleesing JJ, Filipovich AH.

Clin Immunol. 2009 Jul;132(1):116-23. doi: 10.1016/j.clim.2009.03.517. Epub 2009 Apr 23.

6.

A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiency.

Marsh RA, Villanueva J, Zhang K, Snow AL, Su HC, Madden L, Mody R, Kitchen B, Marmer D, Jordan MB, Risma KA, Filipovich AH, Bleesing JJ.

Cytometry B Clin Cytom. 2009 Sep;76(5):334-44. doi: 10.1002/cyto.b.20473.

7.

Small molecule XIAP inhibitors cooperate with TRAIL to induce apoptosis in childhood acute leukemia cells and overcome Bcl-2-mediated resistance.

Fakler M, Loeder S, Vogler M, Schneider K, Jeremias I, Debatin KM, Fulda S.

Blood. 2009 Feb 19;113(8):1710-22. doi: 10.1182/blood-2007-09-114314. Epub 2008 Nov 25.

8.

XIAP regulates cytosol-specific innate immunity to Listeria infection.

Bauler LD, Duckett CS, O'Riordan MX.

PLoS Pathog. 2008 Aug 29;4(8):e1000142. doi: 10.1371/journal.ppat.1000142.

9.

Natural killer T cells and X-linked lymphoproliferative syndrome.

Latour S.

Curr Opin Allergy Clin Immunol. 2007 Dec;7(6):510-4. Review.

PMID:
17989527
10.

Hemophagocytic syndromes.

Janka GE.

Blood Rev. 2007 Sep;21(5):245-53. Epub 2007 Jun 21. Review.

PMID:
17590250
11.

Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules.

Ma CS, Nichols KE, Tangye SG.

Annu Rev Immunol. 2007;25:337-79. Review.

PMID:
17201683
12.

XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome.

Rigaud S, Fondan├Ęche MC, Lambert N, Pasquier B, Mateo V, Soulas P, Galicier L, Le Deist F, Rieux-Laucat F, Revy P, Fischer A, de Saint Basile G, Latour S.

Nature. 2006 Nov 2;444(7115):110-4.

PMID:
17080092
13.

HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Henter JI, Horne A, Aric├│ M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G.

Pediatr Blood Cancer. 2007 Feb;48(2):124-31.

PMID:
16937360
14.

Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis.

Molleran Lee S, Villanueva J, Sumegi J, Zhang K, Kogawa K, Davis J, Filipovich AH.

J Med Genet. 2004 Feb;41(2):137-44. No abstract available.

15.

Uncoupling of the signaling and caspase-inhibitory properties of X-linked inhibitor of apoptosis.

Lewis J, Burstein E, Reffey SB, Bratton SB, Roberts AB, Duckett CS.

J Biol Chem. 2004 Mar 5;279(10):9023-9. Epub 2003 Dec 29.

16.

X-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor-beta signaling.

Birkey Reffey S, Wurthner JU, Parks WT, Roberts AB, Duckett CS.

J Biol Chem. 2001 Jul 13;276(28):26542-9. Epub 2001 May 16.

17.

Characterization of XIAP-deficient mice.

Harlin H, Reffey SB, Duckett CS, Lindsten T, Thompson CB.

Mol Cell Biol. 2001 May;21(10):3604-8.

18.

Activation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1.

Hofer-Warbinek R, Schmid JA, Stehlik C, Binder BR, Lipp J, de Martin R.

J Biol Chem. 2000 Jul 21;275(29):22064-8.

19.

XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway.

Yamaguchi K, Nagai S, Ninomiya-Tsuji J, Nishita M, Tamai K, Irie K, Ueno N, Nishida E, Shibuya H, Matsumoto K.

EMBO J. 1999 Jan 4;18(1):179-87.

20.

Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome.

Nichols KE, Harkin DP, Levitz S, Krainer M, Kolquist KA, Genovese C, Bernard A, Ferguson M, Zuo L, Snyder E, Buckler AJ, Wise C, Ashley J, Lovett M, Valentine MB, Look AT, Gerald W, Housman DE, Haber DA.

Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13765-70.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk